The gut microbiota has gained immense interest in chronic kidney disease. Dysbiosis describes both quantitative and qualitative changes in microbiota composition and function in disease. CKD dysbiosis has been associated with reduced species richness, a decrease in beneficial bacteria such as Lactobacillus and Bifidobacterium, and an increase in pathogens such as Enterobacteriaceae. Additionally, the gut microbiota has a role in the progression of CKD through the production of microbiome-derived uraemic toxins.
No takes yet. Share an insight, caveat, or question.
MOHAMED et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: